Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2013-06-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy of Non Invasive Hemoglobin Measure by SpHb Device in Post Operative Anemia Diagnosis
NCT06497335
Non-invasive Measurement of Hemoglobin Concentration With Pulse Co-oximetry
NCT01060683
Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range
NCT03816514
Intraoperative Continuous Noninvasive Hemoglobin Monitoring in Patients Undergoing Thoracic Surgery
NCT07135492
Blood Loss Quantification During Major Abdominal Surgery
NCT05316649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hb group:15 patients
scheduled for elective surgery associated with undetected, i.e., difficult to reliably monitor intraoperative blood loss.
blood transfusion, intermittent Hbsatlab measurement
In the Hbsatlab group, RBC administration and its timing will be based on intermittent Hbsatlab measurement (routine care)
SpHb group: 15 patients
scheduled for elective surgery associated with undetected, i.e., difficult to reliably monitor intraoperative blood loss.
blood transfusion, based on continuous SpHb readings
RBC administration and its timing will be based on continuous SpHb readings while Hbsatlab values, measured every 30 min. by an objective observer, will not be visible to the attending anaesthetist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood transfusion, intermittent Hbsatlab measurement
In the Hbsatlab group, RBC administration and its timing will be based on intermittent Hbsatlab measurement (routine care)
blood transfusion, based on continuous SpHb readings
RBC administration and its timing will be based on continuous SpHb readings while Hbsatlab values, measured every 30 min. by an objective observer, will not be visible to the attending anaesthetist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) classification I, II, III, IV
Exclusion Criteria
* Emergency surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof.dr.T.W.L.Scheeren
Prof.dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel M.R.F. Struys, Prof.dr
Role: PRINCIPAL_INVESTIGATOR
University of groningen,University Medical Center Groningen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Groningen
Groningen, Provincie Groningen, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
bleeding SpHb-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.